United States

People: Atossa Genetics Inc (ATOS.OQ)

ATOS.OQ on NASDAQ Stock Exchange Capital Market

14 Dec 2018
Change (% chg)

$0.04 (+3.36%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Atha, Cindy 

Ms. Cindy Atha is Vice President of Sales and Marketing of Atossa Genetics Inc. Prior to joining Atossa, Ms. Atha was Vice President of Managed Markets for Depomed, leading a team that focused on third party reimbursement, pricing, and distribution management. While Vice President of Managed Markets and Trade at Amylin Pharmaceuticals, her team was twice recognized for "Best Marketing Programs and People" for a small manufacturer, and also achieved the 2012 DIANA Award for best new product introduction. Ms. Atha began her 24 years of pharmaceutical experience in field sales with Merck & Co. and then moved to AstraZeneca where she advanced into senior sales leadership. She has received more than 16 sales awards for exceptional individual and group performance including AstraZeneca's prestigious "Leadership Excellence Award." Ms. Atha helped bring over 15 new pharmaceutical products to market and she gained formative experience as an account executive with scientific technologies, promoting the sale of research and medical equipment to leading biotechnology companies and medical centers. She also serves on the Board of Directors for Operation of Hope, a non-profit organization that provides facial reconstructive surgeries to poor children around the world. Ms. Atha received her Bachelor of Science in Zoology from North Carolina State University in Raleigh, North Carolina.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Steven Quay


Kyle Guse


Cindy Atha


Janet Rea


Shu-Chih Chen


Stephen Galli

As Of  30 Dec 2014